Pavlidis, G., Papageorgiou, S. G., Bazani, E., Bouchla, A., Glezou, E., Gkontopoulos, K., . . . Vlahakos, D. V. (2021). Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes. Ther Adv Hematol.

Pavlidis, George, Sotirios G. Papageorgiou, Efthimia Bazani, Anthi Bouchla, Eirini Glezou, Konstantinos Gkontopoulos, Thomas Thomopoulos, Vasiliki Pappa, و Demetrios V. Vlahakos. "Discontinuation of the Renin–angiotensin System Inhibitors Improves Erythropoiesis in Patients With Lower-risk Myelodysplastic Syndromes." Ther Adv Hematol 2021.

Pavlidis, George, et al. "Discontinuation of the Renin–angiotensin System Inhibitors Improves Erythropoiesis in Patients With Lower-risk Myelodysplastic Syndromes." Ther Adv Hematol 2021.